MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from shares sold
for cash
$3,044,054
Net cash from
financing activities
$3,044,054
Effect of exchange rate
changes on cash
$20,635
Net change in cash
for the period
$846,908
Canceled cashflow
$2,217,781
something is missing
$3,195,006
Prepaid expenses and
deposits
-$391,739
Stock based
compensation
$74,895
Accounts receivable
-$46,015
Depreciation and
amortization
$19,101
Noncash lease expense
$7,467
Lease accretion
$1,802
Short-term investments
$2,001
Net cash used in
operating activities
-$2,163,872
Net cash used in
investing activities
-$53,909
Canceled cashflow
$3,736,025
Canceled cashflow
$2,001
Net loss
-$4,647,738
Purchase of equipment
$40,816
Additions to intellectual
property
$15,094
Accounts payable and
accrued liabilities
-$1,242,824
Operating lease liability
-$9,335
Back
Back
Cash Flow
Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Corp. (LEXX)
source: myfinsight.com